General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 171: Which of the following is not a genetic cause of hypercoagulability?

A. Factor V mutation
B. Antithrombin III deficiency
C. Antiphospholipid antibody syndrome (Correct Answer)
D. Protein C deficiency

Explanation: Explanation: Hypercoagulability (thrombophilia) is broadly classified into **Primary (Genetic/Inherited)** and **Secondary (Acquired)** disorders [1]. **Why Antiphospholipid Antibody Syndrome (APS) is the correct answer:** APS is an **acquired** autoimmune condition characterized by the presence of antibodies (such as Lupus Anticoagulant or Anti-cardiolipin antibodies) that attack phospholipids [2]. It leads to recurrent arterial/venous thrombosis and pregnancy loss [3]. Unlike the other options, it is not caused by an inherited genetic mutation but is developed during a person's lifetime, often secondary to SLE [2]. **Analysis of Incorrect Options:** * **Factor V Mutation (Factor V Leiden):** This is the **most common** genetic cause of inherited hypercoagulability [1]. A point mutation (glutamine to arginine substitution) makes Factor V resistant to inactivation by Protein C [1]. * **Antithrombin III Deficiency:** An inherited deficiency of this natural anticoagulant leads to an inability to neutralize thrombin and Factor Xa, significantly increasing clot risk. * **Protein C Deficiency:** Protein C is a Vitamin K-dependent natural anticoagulant. An inherited deficiency prevents the degradation of Factors Va and VIIIa, leading to a prothrombotic state (and a risk of Warfarin-induced skin necrosis). **High-Yield Clinical Pearls for NEET-PG:** * **Most common inherited cause:** Factor V Leiden [1]. * **Most common acquired cause:** Prolonged immobilization/Surgery (though APS is a classic "medical" acquired cause). * **Prothrombin G20210A:** The second most common genetic cause; it leads to increased prothrombin levels [1]. * **Hyperhomocysteinemia:** Can be both genetic (MTHFR mutation) and acquired (Vitamin B12/Folate deficiency). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 133-134. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 134-135. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 626-627.

Question 172: Which of the following is not typically seen in cystic fibrosis?

A. Limb anomalies (Correct Answer)
B. Meconium ileus
C. Female infertility
D. Lung infection

Explanation: **Explanation:** Cystic Fibrosis (CF) is an autosomal recessive multisystem disorder caused by mutations in the **CFTR gene** on chromosome 7 [1]. This defect leads to abnormal chloride transport, resulting in thick, viscid secretions in the exocrine glands [2]. **Why Limb Anomalies is the Correct Answer:** Limb anomalies are **not** a feature of Cystic Fibrosis [1]. CF primarily affects epithelial transport in the lungs, pancreas, intestines, and reproductive tract [4]. Limb development is embryologically distinct and is not influenced by the CFTR protein defect. **Analysis of Incorrect Options:** * **Meconium Ileus:** This is the earliest clinical manifestation of CF, seen in about 15-20% of affected newborns. Thick, inspissated mucus causes small bowel obstruction [1]. * **Female Infertility:** While most males with CF are sterile (due to Congenital Bilateral Absence of the Vas Deferens - CBAVD) [4], females often experience reduced fertility due to abnormally thick cervical mucus that acts as a barrier to sperm penetration. * **Lung Infection:** This is the most common cause of morbidity and mortality [3]. Viscous mucus leads to impaired mucociliary clearance, resulting in chronic colonization by pathogens like *Staphylococcus aureus* and *Pseudomonas aeruginosa* [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Sweat Chloride Test (Chloride >60 mmol/L) [4]. * **Most Common Mutation:** ΔF508 (Class II mutation - protein misfolding and degradation) [1]. * **Pancreas:** Leads to exocrine insufficiency, malabsorption, and steatorrhea [1]. * **Nasal Polyps:** Recurrent nasal polyps in a child should always prompt an evaluation for Cystic Fibrosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, p. 476. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Lumen Of Sweat Duct, pp. 475-476. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, p. 478. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 478-479.

Question 173: When leukocytes are arranged along the endothelium of blood vessels it is called?

A. Diapedesis
B. Adhesion
C. Margination (Correct Answer)
D. Chemotaxis

Explanation: ### Explanation **Correct Answer: C. Margination** **Mechanism:** In the early stages of acute inflammation, hemodynamic changes occur [1]. Normally, blood cells travel in the central axial column of the vessel, while plasma moves near the vessel wall (laminar flow). As inflammation triggers **vasodilation** and increased vascular permeability, blood flow slows down (**stasis**). As the flow slows, the heavier leukocytes (WBCs) are pushed out of the central column toward the periphery, where they settle and arrange themselves along the vascular endothelium [1]. This peripheral displacement is known as **Margination** [1]. **Analysis of Incorrect Options:** * **A. Diapedesis (Transmigration):** This is the process where leukocytes squeeze through the inter-endothelial gaps to exit the blood vessel into the extravascular space [4]. It occurs *after* adhesion. * **B. Adhesion:** This refers to the firm attachment of leukocytes to the endothelial surface, mediated by **Integrins** (on WBCs) and **ICAM-1/VCAM-1** (on endothelium) [2]. Margination precedes adhesion. * **D. Chemotaxis:** This is the unidirectional movement of leukocytes toward the site of injury along a chemical gradient (e.g., C5a, LTB4, IL-8) [3]. This occurs *outside* the vessel in the interstitial tissue. **High-Yield Clinical Pearls for NEET-PG:** * **Sequence of Leukocyte Extravasation:** Margination → Rolling → Adhesion → Diapedesis (Transmigration) → Chemotaxis [1]. * **Rolling** is mediated by **Selectins** (E, P, and L-selectin) [2]. * **Adhesion** is mediated by **Integrins** [2]. * **Diapedesis** primarily occurs in the **post-capillary venules** and is mediated by **PECAM-1 (CD31)** [3]. * **Leukocyte Adhesion Deficiency (LAD) Type 1** is a defect in Integrins (CD18), leading to failed adhesion and recurrent infections without pus formation [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Migration in the tissues toward a chemotactic stimulus, pp. 86-87. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 87. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 87-89. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 188-189.

Question 174: I-cell disease is associated with which organelle?

A. Golgi apparatus
B. Lysosomes (Correct Answer)
C. Peroxisomes
D. Mitochondria

Explanation: **Explanation:** **I-cell disease (Inclusion Cell Disease)**, or Mucolipidosis II, is a rare autosomal recessive lysosomal storage disorder [1]. **Why Lysosomes are the correct answer:** The fundamental defect in I-cell disease is a deficiency of the enzyme **N-acetylglucosamine-1-phosphotransferase**. Normally, this enzyme phosphorylates mannose residues on newly synthesized acid hydrolases in the Golgi apparatus, creating a **Mannose-6-Phosphate (M6P)** tag [1]. This tag acts as a "zip code" that targets these enzymes to the **lysosomes**. In I-cell disease, the lack of this tag causes the enzymes to be secreted extracellularly rather than being delivered to the lysosomes. Consequently, lysosomes lack the necessary degradative enzymes, leading to the accumulation of undigested substrates as "inclusion bodies" (hence the name I-cell) [1]. **Why other options are incorrect:** * **Golgi apparatus:** While the biochemical defect (phosphorylation) occurs within the Golgi, the disease is classified as a **lysosomal storage disorder** because the clinical and pathological consequences manifest due to lysosomal dysfunction [1]. * **Peroxisomes:** These are involved in long-chain fatty acid oxidation (e.g., Zellweger syndrome), not M6P-mediated enzyme targeting. * **Mitochondria:** These are involved in ATP production and apoptosis; defects here lead to mitochondrial myopathies (e.g., MELAS). **High-Yield Clinical Pearls for NEET-PG:** * **Biochemical Hallmark:** High levels of lysosomal enzymes in the **blood/plasma** but absent within the cells. * **Clinical Features:** Coarse facial features, gingival hyperplasia, craniofacial abnormalities, joint contractures, and severe psychomotor retardation. * **Diagnosis:** Presence of intracytoplasmic inclusions in fibroblasts. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 159-161.

Question 175: Red infarct is typically seen in which organ?

A. Lungs (Correct Answer)
B. Spleen
C. Kidney
D. Heart

Explanation: **Explanation:** Infarcts are classified based on their color into **Red (Hemorrhagic)** and **White (Anemic)**. The primary determinant is the vascular supply and the density of the tissue [1]. **Why Lungs (Option A) is Correct:** Red infarcts occur in tissues with a **dual blood supply** or loose, spongy textures that allow blood to collect in the infarcted area [1]. The lungs have a dual supply from the **Pulmonary and Bronchial arteries** [2]. When an obstruction occurs, the loose alveolar tissue allows blood from the collateral supply to seep into the necrotic area, giving it a red, hemorrhagic appearance. Other sites for red infarcts include the small intestine (dual supply/venous torsion), brain (liquefactive necrosis), and tissues following venous occlusion (e.g., testicular torsion). **Why Other Options are Incorrect:** * **Spleen (Option B) and Kidney (Option C):** These are solid, compact organs with **end-arterial circulation**. When an artery is blocked, there is no collateral flow to "fill" the necrotic area [1]. The lack of blood results in a pale, wedge-shaped **White Infarct** [1]. * **Heart (Option D):** The myocardium is a solid tissue with functional end-arteries. Myocardial infarctions are typically **White Infarcts** [1]. **High-Yield NEET-PG Pearls:** * **White Infarcts:** Occur in solid organs with single-vessel supply (Heart, Spleen, Kidney) [1]. * **Red Infarcts:** Occur in organs with dual supply (Lungs, Liver, GI tract), loose tissues, or following **reperfusion** of a previously ischemic area [1]. * **Morphology:** Most infarcts are wedge-shaped, with the apex pointing toward the site of vascular occlusion [1]. * **Microscopy:** The hallmark of most infarcts is **Ischemic Coagulative Necrosis** (Exception: Brain, which undergoes Liquefactive Necrosis). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 140. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 137-138.

Question 176: Massive splenomegaly is not a feature of which of the following conditions?

A. Acute lymphocytic leukemia (Correct Answer)
B. Chronic myeloid leukemia
C. Myelofibrosis with myeloid metaplasia
D. Hairy cell leukemia

Explanation: In pathology, splenomegaly is categorized by weight and size. **Massive splenomegaly** (spleen weight >1000g or extending into the right iliac fossa) is typically seen in chronic conditions where there is prolonged infiltration or compensatory work. ### Why Acute Lymphocytic Leukemia (ALL) is the correct answer: In **Acute Lymphocytic Leukemia (ALL)**, the disease progression is rapid and aggressive. The malignant lymphoblasts proliferate so quickly that the patient usually presents with bone marrow failure symptoms (anemia, infections, bleeding) before the spleen has sufficient time to enlarge significantly [1]. While mild to moderate splenomegaly is common in ALL, it rarely, if ever, reaches "massive" proportions [1]. ### Why the other options are incorrect: * **Chronic Myeloid Leukemia (CML):** This is the classic cause of massive splenomegaly [2]. The slow, indolent nature of the chronic phase allows the spleen to become a massive reservoir for neoplastic cells, which may fill the abdominal cavity [2]. * **Myelofibrosis with Myeloid Metaplasia:** As the bone marrow becomes fibrotic, the spleen takes over hematopoiesis (**Extramedullary Hematopoiesis**) [3]. This compensatory workload leads to some of the largest spleens seen in clinical practice [3]. * **Hairy Cell Leukemia:** This is a chronic B-cell lymphoproliferative disorder characterized by marked infiltration of the splenic red pulp, making massive splenomegaly a hallmark diagnostic feature [4]. ### NEET-PG High-Yield Pearls: * **Causes of Massive Splenomegaly (Mnemonic: "2M, 2C, 2H"):** **M**yelofibrosis, **M**alaria (Chronic/Tropical) [5], **C**ML [2], **C**ala-azar (Leishmaniasis) [5], **H**airy Cell Leukemia [4], **H**aucher’s Disease (Gaucher). * **Splenic Infarction:** Massive splenomegaly predisposes patients to splenic infarcts due to the blood supply outstripping the organ's growth [2], [3]. * **Acute vs. Chronic:** As a general rule for exams, "Acute" leukemias cause mild/moderate enlargement [1], while "Chronic" leukemias cause massive enlargement [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 608-610. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 611-612. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 628-629. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 612. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 568-569.

Question 177: Which of the following periapical conditions is often associated with a vital pulp?

A. Apical cyst
B. Apical scar
C. Condensing osteitis (Correct Answer)
D. Chronic apical periodontitis

Explanation: **Explanation:** **Condensing Osteitis (Chronic Focal Sclerosing Osteomyelitis)** is a unique periapical inflammatory reaction characterized by localized bony proliferation (sclerosis) rather than bone resorption [1]. It typically occurs in response to a low-grade, chronic inflammatory stimulus, such as mild pulpitis. Unlike most periapical lesions, the pulp in the affected tooth is often **vital** (though it may be inflamed/diseased) or only partially necrotic. This is because the body’s defensive response is robust enough to produce bone rather than succumb to extensive necrosis. **Analysis of Incorrect Options:** * **Apical Cyst (Radicular Cyst):** This is a sequel to a periapical granuloma [2]. It occurs only after the pulp has undergone complete necrosis; therefore, the tooth is always **non-vital**. * **Apical Scar:** This represents dense collagenous tissue formed during the healing of a periapical lesion (often post-endodontic surgery). It occurs in teeth that were previously necrotic or treated, hence not associated with a vital pulp. * **Chronic Apical Periodontitis (Periapical Granuloma):** This is a localized mass of chronic inflammatory tissue at the apex of a **non-vital** tooth [2]. The death of the pulp is a prerequisite for the formation of this lesion. **NEET-PG High-Yield Pearls:** * **Radiographic Appearance:** Condensing osteitis presents as a well-defined radiopacity at the apex, often with a visible periodontal ligament (PDL) space (unlike idiopathic osteosclerosis). * **Common Site:** Most frequently seen in the **mandibular first molar** of young adults [1]. * **Key Distinction:** If the pulp tests vital, the condition is likely Condensing Osteitis; if non-vital, it is likely a periapical granuloma or cyst. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1197-1198. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 741-742.

Question 178: Acute cellular rejection following solid organ transplantation typically occurs when?

A. Within minutes to hours of transplantation
B. Within 48 hours of transplantation
C. Between 5 and 30 days of transplantation (Correct Answer)
D. Beyond 30 days after transplantation

Explanation: **Explanation:** **1. Why Option C is Correct:** Acute cellular rejection is a **Type IV hypersensitivity reaction** (cell-mediated) primarily driven by host T-lymphocytes (CD8+ and CD4+) reacting against the donor's HLA antigens [3], [4]. This process requires time for the activation and proliferation of T-cells and their subsequent infiltration into the graft [4]. While it can occur anytime, it typically manifests between **5 and 30 days** post-transplantation in an non-sensitized individual. Histologically, it is characterized by interstitial mononuclear cell infiltration and endothelitis [1]. **2. Why Other Options are Incorrect:** * **Options A & B (Minutes to 48 hours):** These timeframes describe **Hyperacute Rejection**. This is a **Type II hypersensitivity reaction** caused by pre-formed anti-donor antibodies (e.g., ABO incompatibility). It occurs immediately upon reperfusion, leading to thrombosis and graft necrosis [1]. * **Option D (Beyond 30 days):** While acute rejection *can* occur months later (often due to tapering of immunosuppression), "beyond 30 days" (specifically months to years) is the classic timeframe for **Chronic Rejection**. Chronic rejection involves Type II and IV reactions, leading to intimal fibrosis (arteriosclerosis) and organ atrophy. **3. NEET-PG High-Yield Pearls:** * **Hyperacute Rejection:** Pre-formed antibodies; Fibrinoid necrosis and thrombosis [1]. * **Acute Cellular Rejection:** T-cell mediated; Mononuclear infiltrate; Reversible with steroids/immunosuppressants [1], [2]. * **Acute Humoral Rejection:** B-cell mediated (anti-HLA antibodies); Characterized by **C4d deposition** in capillaries. * **Chronic Rejection:** Dominant feature is **Graft Vascular Sclerosis** (concentric intimal thickening). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 242. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 180-181. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 174-175. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 240-241.

Question 179: Hallmark of tuberculous inflammation are all, except:

A. Caseous necrosis
B. Langhan's cells
C. Epithelioid cell granuloma
D. Liquefactive necrosis (Correct Answer)

Explanation: **Explanation:** Tuberculosis (TB) is the classic example of **chronic granulomatous inflammation** caused by *Mycobacterium tuberculosis*. The hallmark of this process is the formation of a **tuberculous granuloma** (tubercle) [1]. **Why Liquefactive Necrosis is the Correct Answer:** Liquefactive necrosis is characterized by the transformation of tissue into a liquid, viscous mass, typically seen in bacterial/fungal infections (abscess formation) or hypoxic death of cells within the central nervous system (brain infarcts). It is **not** a feature of tuberculosis, which is instead defined by **Caseous Necrosis** [1]. **Analysis of Incorrect Options:** * **Caseous Necrosis:** This is the pathognomonic feature of TB. It appears macroscopically as "cheese-like" white debris and microscopically as eosinophilic, structureless, amorphous material [1]. It results from a combination of coagulative necrosis and the lipid-rich cell walls of Mycobacteria. * **Epithelioid Cell Granuloma:** The fundamental unit of TB inflammation. Epithelioid cells are activated macrophages that resemble epithelial cells (elongated nuclei, abundant pink cytoplasm) [2]. They are induced by IFN-gamma secreted by CD4+ T-cells (Type IV Hypersensitivity). * **Langhans Giant Cells:** These are multinucleated giant cells formed by the fusion of epithelioid cells [2]. They characteristically show nuclei arranged in a "horseshoe" pattern at the periphery. **High-Yield Pearls for NEET-PG:** * **Hard Granuloma:** A granuloma without central caseation (often seen in Sarcoidosis). * **Soft Granuloma:** A granuloma with central caseation (typical of TB) [1]. * **Stain:** *Mycobacterium tuberculosis* is visualized using the **Ziehl-Neelsen (Acid-Fast) stain** [1]. * **Cytokine Key:** **TNF-alpha** is essential for maintaining granuloma integrity; anti-TNF therapy can lead to the breakdown of granulomas and reactivation of latent TB. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 383-384. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 109.

Question 180: All of the following are inhibitors of cell cycle progression except?

A. P21
B. P27
C. p16INK4a
D. CDK2 (Correct Answer)

Explanation: **Explanation:** The cell cycle is strictly regulated by a balance between **Cyclins/Cyclin-Dependent Kinases (CDKs)**, which promote progression, and **CDK Inhibitors (CDKIs)**, which halt it [1]. **Why CDK2 is the correct answer:** CDK2 is a **pro-survival/pro-proliferative kinase**. It complexes with Cyclin E to facilitate the G1/S transition and with Cyclin A to drive the S phase [1]. Unlike the other options, CDK2 does not inhibit the cell cycle; rather, its activation is essential for DNA replication and cell division [1]. **Why the other options are incorrect:** The other options belong to two major families of **CDK Inhibitors (CDKIs)**: * **p21 and p27 (Cip/Kip Family):** These are broad-spectrum inhibitors. **p21** is famously induced by the tumor suppressor **p53** in response to DNA damage, while **p27** responds to growth-inhibitory signals like TGF-β [2]. They bind to and inhibit Cyclin-CDK complexes (especially CDK2 and CDK4) [1]. * **p16INK4a (INK4 Family):** This specifically inhibits **CDK4 and CDK6**, preventing them from binding to Cyclin D [3]. This keeps the Retinoblastoma (Rb) protein in a hypophosphorylated (active) state, which arrests the cell in the G1 phase [1]. **High-Yield Clinical Pearls for NEET-PG:** * **G1-S Checkpoint:** The most critical "restriction point" in the cell cycle [1]. * **p53 Pathway:** DNA damage → ↑p53 → ↑p21 → Inhibition of CDK2/Cyclin E → Cell cycle arrest [2]. * **Clinical Correlation:** Loss of **p16** is frequently seen in many cancers (e.g., pancreatic cancer, melanoma), leading to uncontrolled entry into the S-phase [1]. * **Mnemonic:** **INK4** family (p15, p16, p18, p19) acts only on **CDK4/6** [3]. The **Cip/Kip** family (p21, p27, p57) acts on **all** CDKs. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-301. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 37-38.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free